143 related articles for article (PubMed ID: 6390858)
1. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
Thomas J; Whitley T; Carver M; Thomas F
Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858
[No Abstract] [Full Text] [Related]
2. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
[No Abstract] [Full Text] [Related]
3. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
[No Abstract] [Full Text] [Related]
4. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
5. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
6. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
[No Abstract] [Full Text] [Related]
7. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
[No Abstract] [Full Text] [Related]
8. Cardiac allograft survival in rhesus primates treated with total lymphoid irradiation and rabbit antithymocyte globulin.
Bieber CP; Jamieson SW; Raney A; Burton NA; Bogarty S; Hoppe R; Kaplan HS; Strober S; Stinson EB
Surg Forum; 1979; 30():284-6. PubMed ID: 120018
[No Abstract] [Full Text] [Related]
9. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
Thomas JM; Carver FM; Thomas FT
Surg Forum; 1979; 30():282-3. PubMed ID: 120017
[No Abstract] [Full Text] [Related]
10. Induction of allogeneic unresponsiveness to renal transplants in rhesus monkeys.
Thomas J; Carver M; Sash C; Cunningham P; Thomas F
Transplant Proc; 1987 Oct; 19(5):4070-2. PubMed ID: 3313998
[No Abstract] [Full Text] [Related]
11. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
Hayes JM; Novick AC; Steinmuller DR; Streem SB; Hodge EE; Bretan PN; Cunningham R; Graneto D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):209-14. PubMed ID: 3291245
[No Abstract] [Full Text] [Related]
12. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
[No Abstract] [Full Text] [Related]
13. Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.
Hiesse C; Fries D; Charpentier B; Neyrat N; Rieu P; Cantarovich M; Lantz O; Bellamy J; Benoit G
Transplant Proc; 1987 Oct; 19(5):3670-1. PubMed ID: 3313885
[No Abstract] [Full Text] [Related]
14. Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial.
Grundmann R; Wienand P; Hesse U
Transplant Proc; 1987 Oct; 19(5):4033-4. PubMed ID: 3313993
[No Abstract] [Full Text] [Related]
15. Rat fetal pancreas allograft survival is enhanced following donor tissue organ culture and host immunosuppression.
Bowen KM; Thompson S; Burton RC
Transplant Proc; 1987 Apr; 19(2):2926-9. PubMed ID: 3105132
[No Abstract] [Full Text] [Related]
16. Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
Sollinger HW; Deierhoi M; Kalayoglu M; Belzer FO
Transplant Proc; 1986 Apr; 18(2 Suppl 1):16-8. PubMed ID: 3515685
[No Abstract] [Full Text] [Related]
17. Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients.
Valderrábano F; Anaya F; Robles NR; Jofré R
Transplant Proc; 1988 Oct; 20(5 Suppl 6):75-8. PubMed ID: 3051597
[No Abstract] [Full Text] [Related]
18. [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].
Petrányi G; Szegedi G; Fekete B
Orv Hetil; 1971 Aug; 112(31):1852-5. PubMed ID: 4941976
[No Abstract] [Full Text] [Related]
19. Effect of immunosuppression on pancreatic graft survival and function.
La Rocca E; Dubernard JM; Camozzi L; LeFrancois N; Faure JL; Sanseverino R; Melandri M; Finaz J; Martin X; Gelet A
Transplant Proc; 1987 Oct; 19(5):3950-2. PubMed ID: 3313972
[No Abstract] [Full Text] [Related]
20. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
